fenebrutinib
Fenebrutinib Shows Promising Results in Relapsing Multiple Sclerosis Treatment
Fenebrutinib, Relapsing Multiple Sclerosis, BTK Inhibitor, Roche, Clinical Trials
Roche’s Fenebrutinib Shows Promising Results in Relapsing Multiple Sclerosis Phase II Trial
Roche, fenebrutinib, relapsing multiple sclerosis, BTK inhibitor, Phase II trial, FENopta study